Session

The gut microbiome as a driver of disease

A NOVEL SUBSET OF IFNG-PRODUCING TH17 SUBSET IS SELECTIVELY ASSOCIATED WITH INTESTINAL INFLAMMATION IN CROHN’S DISEASE AND SPECIFICALLY ACTIVATED BY ADHERENT-INVASIVE ESCHERICHIA COLI (AIEC)
A NOVEL SUBSET OF IFNG-PRODUCING TH17 SUBSET IS SELECTIVELY ASSOCIATED WITH INTESTINAL INFLAMMATION IN CROHN’S DISEASE AND SPECIFICALLY ACTIVATED BY ADHERENT-INVASIVE ESCHERICHIA COLI (AIEC)

The gut microbiome as a driver of disease  et al.

THE GUT MICROBIOME IN END-STAGE LUNG DISEASE AND LUNG TRANSPLANTATION
THE GUT MICROBIOME IN END-STAGE LUNG DISEASE AND LUNG TRANSPLANTATION

The gut microbiome as a driver of disease  et al.

FECAL MICROBIOTA TRANSPLANTATION, BRAIN-GUT-MICROBIOTA AXIS, AMYOTROPHIC LATERAL SCLEROSIS
FECAL MICROBIOTA TRANSPLANTATION, BRAIN-GUT-MICROBIOTA AXIS, AMYOTROPHIC LATERAL SCLEROSIS

The gut microbiome as a driver of disease  et al.

THE GUT MICROBIOME IN END-STAGE LUNG DISEASE AND LUNG TRANSPLANTATION
THE GUT MICROBIOME IN END-STAGE LUNG DISEASE AND LUNG TRANSPLANTATION

A NOVEL SUBSET OF IFNG-PRODUCING TH17 SUBSET IS SELECTIVELY ASSOCIATED WITH INTESTINAL INFLAMMATION IN CROHN’S DISEASE AND SPECIFICALLY ACTIVATED BY ADHERENT-INVASIVE ESCHERICHIA COLI (AIEC)
A NOVEL SUBSET OF IFNG-PRODUCING TH17 SUBSET IS SELECTIVELY ASSOCIATED WITH INTESTINAL INFLAMMATION IN CROHN’S DISEASE AND SPECIFICALLY ACTIVATED BY ADHERENT-INVASIVE ESCHERICHIA COLI (AIEC)

Item 1 - 5 / 5
1